Enron Mail

From:brown_mary_jo@lilly.com
To:alfred.gilman@email.swmed.edu, jterzuoli@ibjwhitehall.com,karen.n.horn@marshmc.com, klay@enron.com, kseifert@kcc.com, prendergast@mayo.edu, scb@purdue.edu
Subject:**PRESS RELEASE**Anti-Hepatitis C Ribozyme Safety and
Cc:
Bcc:
Date:Wed, 13 Sep 2000 02:54:00 -0700 (PDT)

Cc: ewae_johann@lilly.com
Mime-Version: 1.0
Content-Type: text/plain; charset=us-ascii
Content-Transfer-Encoding: 7bit
Bcc: ewae_johann@lilly.com
X-From: BROWN_MARY_JO@LILLY.COM
X-To: alfred.gilman@email.swmed.edu, jterzuoli@ibjwhitehall.com, karen.n.horn@marshmc.com, klay@enron.com, kseifert@kcc.com, prendergast@mayo.edu, scb@purdue.edu
X-cc: EWAE_JOHANN@LILLY.COM
X-bcc:
X-Folder: \Kenneth_Lay_Dec2000\Notes Folders\Discussion threads
X-Origin: LAY-K
X-FileName: klay.nsf

---------------------- Forwarded by Mary Jo Brown/AM/LLY on 09/13/2000
09:48 AM ---------------------------


COLLEEN M PARKER
09/12/2000 10:02 AM


To: Nancy Addington/AM/LLY@Lilly, Patricia A Andrews/AM/LLY@Lilly, Kindra
L Antey/AM/LLY@Lilly, Rhea K Apple/AM/LLY@Lilly, Victoria L
Arthur/AM/LLY@Lilly, Margaret R Ban/AM/LLY@Lilly, Sadie A
Barnett/AM/LLY@Lilly, Lisa E Bayne/AM/LLY@Lilly, Shirley D
Bell/AM/LLY@Lilly, Rebecca S Brawner/AM/LLY@Lilly, Mary Jo
Brown/AM/LLY@Lilly, Cheryl S Bruggenschmidt/AM/LLY@Lilly, Angela C
Byrne/AM/LLY@Lilly, Vickie E Cafaro/AM/LLY@Lilly, Bryce D
Carmine/AP/LLY@Lilly, Jennifer L Clark NONLILLY/AM/LLY@Lilly,
Jacqueline S Coy/AM/LLY@Lilly, Newton F Crenshaw/AM/LLY@Lilly,
Mitchell E Daniels Jr/AM/LLY@Lilly, Blake E Devitt
NONLILLY/AM/LLY@Lilly, Mary Dieter/AM/LLY@Lilly, W Roy
Dunbar/AM/LLY@Lilly, Michael L Eagle/AM/LLY@Lilly, Jalana C
Eash/AM/LLY@Lilly, Kathleen M Edwards/AM/LLY@Lilly, Mary J
Everitt/AM/LLY@Lilly, Rafael D Fernandez/AM/LLY@Lilly, Carrie L
Fisher/AM/LLY@Lilly, Stacey L Fout/AM/LLY@Lilly, Neal F
Fowler/AM/LLY@Lilly, Brendan P Fox Dr/AM/LLY@Lilly, Terra L
Fox/AM/LLY@Lilly, Charles E Golden/AM/LLY@Lilly, Pedro P
Granadillo/AM/LLY@Lilly, Jill E Graves/AM/LLY@Lilly, Thomas W
Grein/AM/LLY@Lilly, Robert W Grupp/AM/LLY@Lilly, Sharolyn A
Hallinin/AM/LLY@Lilly, Arnold C Hanish/AM/LLY@Lilly, James A
Harper/AM/LLY@Lilly, Daniel J Hasler/AM/LLY@Lilly, Jeffrey W
Henderson/AM/LLY@Lilly, Deborah M Hohlt/AM/LLY@Lilly, Terri L Horvath
NONLILLY/AM/LLY@Lilly, Andrew T Hotchkiss/EMA/LLY@Lilly, Ledora
Jacks/AM/LLY@Lilly, Shirley M Johnson/AM/LLY@Lilly, Joseph B
Kelley/AM/LLY@Lilly, Rebecca O Kendall/AM/LLY@Lilly, Gregory A
Kueterman/AM/LLY@Lilly, Shelley K Lambert/AM/LLY@Lilly, John C
Lechleiter/AM/LLY@Lilly, James B Lootens/AM/LLY@Lilly, David J
Marbaugh/AM/LLY@Lilly, Patricia A Martin/AM/LLY@Lilly, Michael
Marvel/AM/LLY@Lilly, Andrew Mascarenhas/AP/LLY@Lilly, Gerhard
Mayr/EMA/LLY@Lilly, Curtis L McDaniel/AM/LLY@Lilly, Dale E
Millington/AM/LLY@Lilly, Mary M Moyer/AM/LLY@Lilly, Cheryl Dawn
Neal/AM/LLY@Lilly, Jeffrey G Newton/AM/LLY@Lilly, Patricia A
Norton/AM/LLY@Lilly, Karen K Phebus/AM/LLY@Lilly, Richard D
Pilnik/AM/LLY@Lilly, Theodore J Planje/AM/LLY@Lilly, Steven R
Plump/AM/LLY@Lilly, Melissa D Pollard/AM/LLY@Lilly, Carol A
Prickett/AM/LLY@Lilly, Karin Ricketts/AM/LLY@Lilly, William R
Ringo/AM/LLY@Lilly, Tracy E Roberts/AM/LLY@Lilly, Mary E
Robinson/AM/LLY@Lilly, Donald A Royston/AM/LLY@Lilly, Julie D
Ruff/AM/LLY@Lilly, Gino Santini/AM/LLY@Lilly, Gail Sax/AM/LLY@Lilly,
Andrea K Smith/AM/LLY@Lilly, Kathleen K Smith NONLILLY/AM/LLY@Lilly,
Michael R Smith/AM/LLY@Lilly, Michael R Smith/AM/LLY@Lilly, Robert
Lee Smith/AM/LLY@Lilly, Gretchen E Spaulding/AM/LLY@Lilly, Rosemary I
Spearing/AM/LLY@Lilly, Jane J Springer/AM/LLY@Lilly, Elizabeth A
Stoneking/AM/LLY@Lilly, Ronald F Stowe/AM/LLY@Lilly, Donna L
Tackett/AM/LLY@Lilly, Sidney Taurel/AM/LLY@Lilly, Michael E
Thyen/AM/LLY@Lilly, Brenda D Turk/AM/LLY@Lilly, Laura M
Tyler/AM/LLY@Lilly, Albertus VanDenBergh/EMA/LLY@Lilly, Mildred L
Vaught/AM/LLY@Lilly, Jeffrey L Wadman/AM/LLY@Lilly, Maryanne
Wagner/AM/LLY@Lilly, August M Watanabe/AM/LLY@Lilly, Jennifer
Yoder/AM/LLY@Lilly
cc:

Subject: **PRESS RELEASE**Anti-Hepatitis C Ribozyme Safety and
Pharmacokinetics Trial Successfully Completed

The attached joint press release was issued by Ribozyme late last night,
Sept. 11.

(See attached file: Ribozyme Joint Release.doc)

COLLEEN PARKER
Corporate Communications
276-3402


- Ribozyme Joint Release.doc